EV/EBITDA
-1.58
-0.07-4.64%
107 min ago
Summary
- As of March 13, 2025, CCCC EV/EBITDA is -1.58, with a fall of -0.07 (-4.64%) during the most recent trading day.
- Over the past year, CCCC EV/EBITDA has increased by +3.85 (+70.90%).
- CCCC EV/EBITDA is now -7800.00% below its all-time high of -0.02.
Performance
CCCC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CCCC EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -4.6% | +5.0% | +5.4% |
1 m1 month | +33.0% | -33.0% | -34.7% |
3 m3 months | +50.6% | -50.6% | -52.9% |
6 m6 months | +62.6% | -63.0% | -66.5% |
ytdytd | +38.3% | -38.1% | -40.0% |
1 y1 year | +70.9% | -76.5% | -80.3% |
5 y5 years | - | - | - |
CCCC EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -4.6% | -2.39 | +33.9% | |
3 m | 3-month | -1.51 | -4.6% | -3.20 | +50.6% |
6 m | 6-month | -1.51 | -4.6% | -4.83 | +67.3% |
1 y | 1-year | -1.51 | -4.6% | -5.46 | +71.1% |
3 y | 3-year | -0.02 | -7800.0% | -14.86 | +89.4% |
5 y | 5-year | -0.02 | -7800.0% | -30.45 | +94.8% |
alltime | all time | -0.02 | -7800.0% | -30.45 | +94.8% |
C4 Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -1.58(-38.3%) |
2024 | -2.56(+13.8%) |
2023 | -2.25(-19.4%) |
Date | Value |
---|---|
2022 | -2.79(-85.4%) |
2021 | -19.12(-3.3%) |
2020 | -19.77 |
FAQ
- What is C4 Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for C4 Therapeutics?
- What is CCCC EV/EBITDA year-to-date change?
- What is C4 Therapeutics EV/EBITDA year-on-year change?
What is C4 Therapeutics EV/EBITDA?
The current EV/EBITDA of CCCC is -1.58
What is the all time high EV/EBITDA for C4 Therapeutics?
C4 Therapeutics all-time high EV/EBITDA is -0.02
What is CCCC EV/EBITDA year-to-date change?
C4 Therapeutics EV/EBITDA has changed by +0.98 (+38.28%) since the beginning of the year
What is C4 Therapeutics EV/EBITDA year-on-year change?
Over the past year, CCCC EV/EBITDA has changed by +3.85 (+70.90%)